AAAAAA

   
Results: 1-25 | 26-49
Results: 1-25/49
Mechanism-related changes in the gene transcription and protein synthesis patterns of Haemophilus influenzae after treatment with transcriptional andtranslational inhibitors
Authors: Evers, S Di Padova, K Meyer, M Langen, H Fountoulakis, M Keck, W Gray, CP
Citation: S. Evers et al., Mechanism-related changes in the gene transcription and protein synthesis patterns of Haemophilus influenzae after treatment with transcriptional andtranslational inhibitors, PROTEOMICS, 1(4), 2001, pp. 522-544
Synaptosomal proteins, beta-soluble N-ethylmaleimide-sensitive factor attachment protein (beta-SNAP), gamma-SNAP and synaptotagmin 1 in brain of patients with Down syndrome and Alzheimer's disease
Authors: Yoo, BC Cairns, N Fountoulakis, M Lubec, G
Citation: Bc. Yoo et al., Synaptosomal proteins, beta-soluble N-ethylmaleimide-sensitive factor attachment protein (beta-SNAP), gamma-SNAP and synaptotagmin 1 in brain of patients with Down syndrome and Alzheimer's disease, DEMENT G C, 12(3), 2001, pp. 219-225
Deterioration of the transcriptional, splicing and elongation machinery inbrain of fetal Down Syndrome
Authors: Freidl, M Gulesserian, T Lubec, G Fountoulakis, M Lubec, B
Citation: M. Freidl et al., Deterioration of the transcriptional, splicing and elongation machinery inbrain of fetal Down Syndrome, J NEUR TR-S, (61), 2001, pp. 47-57
Fetal life in Down Syndrome starts with normal neuronal density but impaired dendritic spines and synaptosomal structure
Authors: Weitzdoerfer, R Dierssen, M Fountoulakis, M Lubec, G
Citation: R. Weitzdoerfer et al., Fetal life in Down Syndrome starts with normal neuronal density but impaired dendritic spines and synaptosomal structure, J NEUR TR-S, (61), 2001, pp. 59-70
Antioxidant proteins in fetal brain: superoxide dismutase-1 (SOD-1) protein is not overexpressed in fetal Down syndrome
Authors: Gulesserian, T Engidawork, E Fountoulakis, M Lubec, G
Citation: T. Gulesserian et al., Antioxidant proteins in fetal brain: superoxide dismutase-1 (SOD-1) protein is not overexpressed in fetal Down syndrome, J NEUR TR-S, (61), 2001, pp. 71-84
Aberrant expression of dihydropyrimidinase related proteins-2,-3 and-4 in fetal Down Syndrome brain
Authors: Weitzdoerfer, R Fountoulakis, M Lubec, G
Citation: R. Weitzdoerfer et al., Aberrant expression of dihydropyrimidinase related proteins-2,-3 and-4 in fetal Down Syndrome brain, J NEUR TR-S, (61), 2001, pp. 95-107
Decreased protein levels of complex I 30-kDa subunit in fetal Down syndrome brains
Authors: Kim, SH Fountoulakis, M Dierssen, M Lubec, G
Citation: Sh. Kim et al., Decreased protein levels of complex I 30-kDa subunit in fetal Down syndrome brains, J NEUR TR-S, (61), 2001, pp. 109-116
Selective upregulation of the ubiquitin-proteasome proteolytic pathway proteins, proteasome zeta chain and isopeptidase T in fetal Down syndrome
Authors: Engidawork, E Juranville, JF Fountoulakis, M Dierssen, M Lubec, G
Citation: E. Engidawork et al., Selective upregulation of the ubiquitin-proteasome proteolytic pathway proteins, proteasome zeta chain and isopeptidase T in fetal Down syndrome, J NEUR TR-S, (61), 2001, pp. 117-130
Unaltered expression of Fas (CD95/APO-1), Caspase-3, Bel-2 and Annexins inbrains of fetal Down syndrome: evidence against increased apoptosis
Authors: Engidawork, E Balic, N Juranville, JF Fountoulakis, M Dierssen, M Lubec, G
Citation: E. Engidawork et al., Unaltered expression of Fas (CD95/APO-1), Caspase-3, Bel-2 and Annexins inbrains of fetal Down syndrome: evidence against increased apoptosis, J NEUR TR-S, (61), 2001, pp. 149-162
Increased brain protein levels of carbonyl reductase and alcohol dehydrogenase in Down Syndrome and Alzheimer's disease
Authors: Balcz, B Kirchner, L Cairns, N Fountoulakis, M Lubec, G
Citation: B. Balcz et al., Increased brain protein levels of carbonyl reductase and alcohol dehydrogenase in Down Syndrome and Alzheimer's disease, J NEUR TR-S, (61), 2001, pp. 193-201
Carbohydrate handling enzymes in fetal Down Syndrome brain
Authors: Kitzmueller, E Greber, S Fountoulakis, M Lubec, G
Citation: E. Kitzmueller et al., Carbohydrate handling enzymes in fetal Down Syndrome brain, J NEUR TR-S, (61), 2001, pp. 203-210
Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down Syndrome
Authors: Kim, SH Fountoulakis, M Cairns, N Lubec, G
Citation: Sh. Kim et al., Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down Syndrome, J NEUR TR-S, (61), 2001, pp. 223-235
Increased protein levels of heterogeneous nuclear ribonucleoprotein A2/B1 in fetal Down syndrome brains
Authors: Kim, SH Dierssen, M Ferreres, JC Fountoulakis, M Lubec, G
Citation: Sh. Kim et al., Increased protein levels of heterogeneous nuclear ribonucleoprotein A2/B1 in fetal Down syndrome brains, J NEUR TR-S, (61), 2001, pp. 273-280
Decreased protein levels of stathmin in adult brains with Down syndrome and Alzheimer's disease
Authors: Cheon, MS Fountoulakis, M Cairns, NJ Dierssen, M Herkner, K Lubec, G
Citation: Ms. Cheon et al., Decreased protein levels of stathmin in adult brains with Down syndrome and Alzheimer's disease, J NEUR TR-S, (61), 2001, pp. 281-288
Expression profiles of proteins in fetal brain with Down syndrome
Authors: Cheon, MS Fountoulakis, M Dierssen, M Ferreres, JC Lubec, G
Citation: Ms. Cheon et al., Expression profiles of proteins in fetal brain with Down syndrome, J NEUR TR-S, (61), 2001, pp. 311-319
Expression patterns of chaperone proteins in cerebral cortex of the fetus with Down Syndrome: dysregulation of T-complex protein 1
Authors: Yoo, BC Fountoulakis, M Dierssen, M Lubec, G
Citation: Bc. Yoo et al., Expression patterns of chaperone proteins in cerebral cortex of the fetus with Down Syndrome: dysregulation of T-complex protein 1, J NEUR TR-S, (61), 2001, pp. 321-334
beta-Amyloid precursor protein, ETS-2 and collagen alpha 1 (VI) chain precursor, encoded on chromosome 21, are not overexpressed in fetal Down syndrome: further evidence against gene dosage effect
Authors: Engidawork, E Balic, N Fountoulakis, M Dierssen, M Greber-Platzer, S Lubec, G
Citation: E. Engidawork et al., beta-Amyloid precursor protein, ETS-2 and collagen alpha 1 (VI) chain precursor, encoded on chromosome 21, are not overexpressed in fetal Down syndrome: further evidence against gene dosage effect, J NEUR TR-S, (61), 2001, pp. 335-346
Reduction of nucleoside diphosphate kinase B, Rab GDP-dissociation inhibitor beta and histidine triad nucleotide-binding protein in fetal Down Syndrome brain
Authors: Weitzdoerfer, R Stolzlechner, D Dierssen, M Ferreres, J Fountoulakis, M Lubec, G
Citation: R. Weitzdoerfer et al., Reduction of nucleoside diphosphate kinase B, Rab GDP-dissociation inhibitor beta and histidine triad nucleotide-binding protein in fetal Down Syndrome brain, J NEUR TR-S, (61), 2001, pp. 347-359
Decreased brain levels of 2 ',3 '-cyclic nucleotide-3 '-phosphodiesterase in Down syndrome and Alzheimer's disease
Authors: Vlkolinsky, R Cairns, N Fountoulakis, M Lubec, G
Citation: R. Vlkolinsky et al., Decreased brain levels of 2 ',3 '-cyclic nucleotide-3 '-phosphodiesterase in Down syndrome and Alzheimer's disease, NEUROBIOL A, 22(4), 2001, pp. 547-553
Effect of strong detergents and chaotropes on the detection of proteins intwo-dimensional gels
Authors: Fountoulakis, M Takacs, B
Citation: M. Fountoulakis et B. Takacs, Effect of strong detergents and chaotropes on the detection of proteins intwo-dimensional gels, ELECTROPHOR, 22(9), 2001, pp. 1593-1602
Two-dimensional database of mouse liver proteins. An update
Authors: Fountoulakis, M Juranville, JF Berndt, P Langen, H Suter, L
Citation: M. Fountoulakis et al., Two-dimensional database of mouse liver proteins. An update, ELECTROPHOR, 22(9), 2001, pp. 1747-1763
Differential expression of molecular chaperones in brain of patients with Down syndrome
Authors: Yoo, BC Vlkolinsky, R Engidawork, E Cairns, N Fountoulakis, M Lubec, G
Citation: Bc. Yoo et al., Differential expression of molecular chaperones in brain of patients with Down syndrome, ELECTROPHOR, 22(6), 2001, pp. 1233-1241
Changes in the brain protein levels following administration of kainic acid
Authors: Krapfenbauer, K Berger, M Lubec, G Fountoulakis, M
Citation: K. Krapfenbauer et al., Changes in the brain protein levels following administration of kainic acid, ELECTROPHOR, 22(10), 2001, pp. 2086-2091
Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down Syndrome
Authors: Yoo, BC Fountoulakis, M Cairns, N Lubec, G
Citation: Bc. Yoo et al., Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down Syndrome, ELECTROPHOR, 22(1), 2001, pp. 172-179
The reduction of NADH Ubiquinone oxidoreductase 24-and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's disease
Authors: Kim, SH Vlkolinsky, R Cairns, N Fountoulakis, M Lubec, G
Citation: Sh. Kim et al., The reduction of NADH Ubiquinone oxidoreductase 24-and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's disease, LIFE SCI, 68(24), 2001, pp. 2741-2750
Risultati: 1-25 | 26-49